Kahramanmaras Sutcu Imam University
ksu.edu.trLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
185
Active
34
Phase 3
0
Total enrollment
16,884
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| SPSIPB block | — | — | — | — | — | 1 | |
| Postoperative analgesia management | — | — | — | — | — | 1 | |
| triamcinolone acetonide | — | — | — | — | — | 1 |
Next readouts
- 2025-08-30
- 2026-05-20
Top conditions
- Cerebral Palsy11
- Postoperative Pain7
- Anxiety7
- Multiple Sclerosis7
- Pain, Postoperative7
- Pain6
- PARKINSON DISEASE (Disorder)4
- Infant Development4
Frequently asked questions about Kahramanmaras Sutcu Imam University
- How many clinical trials does Kahramanmaras Sutcu Imam University have on ClinicalTrials.gov?
- Kahramanmaras Sutcu Imam University is listed as the lead sponsor on 185 clinical trials in ClinicalTrials.gov, 34 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Kahramanmaras Sutcu Imam University's trials are in Phase 3?
- 0 of Kahramanmaras Sutcu Imam University's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Kahramanmaras Sutcu Imam University focus on?
- Kahramanmaras Sutcu Imam University's most-studied conditions on ClinicalTrials.gov are Cerebral Palsy, Postoperative Pain, Anxiety, Multiple Sclerosis, Pain, Postoperative.
- When are Kahramanmaras Sutcu Imam University's next clinical trial readouts?
- Kahramanmaras Sutcu Imam University has 2 upcoming primary-completion readouts tracked here; the soonest is “Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery”, expected around 2025-08-30.